|
FAM104A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.742400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.240600E-01 |
| Normal-vs-Stage2 |
9.541400E-01 |
| Normal-vs-Stage3 |
9.246800E-01 |
| Normal-vs-Stage4 |
7.308200E-01 |
| Stage1-vs-Stage2 |
3.489000E-01 |
| Stage1-vs-Stage3 |
1.905450E-01 |
| Stage1-vs-Stage4 |
9.474000E-02 |
| Stage2-vs-Stage3 |
9.884600E-01 |
| Stage2-vs-Stage4 |
8.413200E-01 |
| Stage3-vs-Stage4 |
8.036000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.995200E-01 |
| Normal-vs-AfricanAmerican |
9.775800E-02 |
| Normal-vs-Asian |
3.209600E-01 |
| Caucasian-vs-AfricanAmerican |
1.630570E-01 |
| Caucasian-vs-Asian |
4.120400E-01 |
| AfricanAmerican-vs-Asian |
5.028800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.548200E-01 |
| Normal-vs-Female |
5.402000E-01 |
| Male-vs-Female |
7.473200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.480620E-01 |
| Normal-vs-Age(41-60Yrs) |
6.141000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.126800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.099800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.598000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.513600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.343800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.043000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.402000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.967800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.430310E-02 |
| Classical-VS-Follicular |
1.227990E-01 |
| Classical-VS-Other |
6.954000E-01 |
| Classical-VS-Normal |
1.417190E-01 |
| Tall-VS-Follicular |
3.379400E-01 |
| Tall-VS-Other |
3.983000E-01 |
| Tall-VS-Normal |
2.157800E-01 |
| Follicular-VS-Other |
8.375600E-01 |
| Follicular-VS-Normal |
8.648800E-01 |
| Other-VS-Normal |
8.265400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.896600E-01 |
| Normal-vs-N1 |
4.447400E-01 |
| N0-vs-N1 |
2.394400E-01 |
|
|
